McKesson In Final Phase Of Negotiating Fee-For-Service Contracts
This article was originally published in The Pink Sheet Daily
Executive Summary
The wholesaler anticipates 80% of compensation from manufacturers will be recorded under the new contract model by Oct. 1. Pfizer continues to be a significant holdout within the transition to fee-for-service, McKesson says.
You may also be interested in...
Wholesalers Forecast More Accurate Sell-Side Margins From Fee-For-Service Contracts
AmerisourceBergen and McKesson expect stability in manufacturer service contracts will allow for clearer focus on arrangements with customers. ABC four-point plan to enhance margins include enhancing generic programs and consolidating distribution centers.
Wholesalers Forecast More Accurate Sell-Side Margins From Fee-For-Service Contracts
AmerisourceBergen and McKesson expect stability in manufacturer service contracts will allow for clearer focus on arrangements with customers. ABC four-point plan to enhance margins include enhancing generic programs and consolidating distribution centers.
Cardinal Sees No Rx Distribution Disruptions After April 1 Fee-For-Service Deadline
Most drug manufacturers have agreed in principle to fee-for-service distribution contracts, Cardinal CEO Walter says. Negotiations are now focused on price, not the methodology for paying wholesalers, he says.